Meraas Unveils Dubai Design District Residential Masterplan, Introducing a World-Class Waterfront Neighbourhood

Meraas unveils Dubai Design District residential masterplan, introducing a world-class waterfront neighbourhood

DUBAI, UAE, Jan. 5, 2026 /PRNewswire/ -- Meraas, a member of Dubai Holding Real Estate, has unveiled an expanded residential masterplan for Dubai Design District (d3), transforming the district into one of Dubai's most desirable creative-led waterfront neighbourhoods. Located between Downtown Dubai and Dubai Creek Harbour, the enhanced masterplan spans 18 million sqft of land. Designed and delivered by Meraas, the neighbourhood blends residenti…

Dubai Design District reveals ambitious plan for expansion

The enhanced plan will introduce canal-front living, cultural quarters, public green spaces and walkable streets, creating an integrated community where residents can live, work and collaborate The post Dubai Design District reveals ambitious plan for expansion appeared first on Gulf Business.

UAE: Meraas unveils d3 masterplan, set to introduce waterfront neighbourhood

Momentum around the district continues to accelerate. Meraas’ recent residential releases at d3 have attracted exceptional demand

Kelun-Biotech Announces Breakthrough Therapy Designation Granted in China for Sacituzumab Tirumotecan (sac-TMT) in Combination with Immunotherapy Pembrolizumab for First-Line Treatment of PD-L1-Positive NSCLC

CHENGDU, China, Jan. 5, 2026 /PRNewswire/ — Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (“Kelun-Biotech” or the “Company,” 6990.HK) today announced that its TROP2-directed antibody-drug conjugate (ADC) sacituzumab tirumotecan (sac-TMT, also known as SKB264/MK-2870) (佳泰莱®) in combination with MSD’s anti-PD-1 monoclonal antibody pembrolizumab (KEYTRUDA®[1]) was granted Breakthrough Therapy Designation (BTD) by the Center for Drug Evaluation …